Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Donein25


V.TLT

RE:RE:RE:RE:RE:Research Capital

I believe it said they would make best efforts to list them. Look at the end...

October 25, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Upside to CR

You are probably right; Q1. 

October 23, 2023

V.TLT

RE:RE:RE:RE:Upside to CR

Why are you throwing numbers like 6 months or a year  around? Read the...

October 23, 2023

V.TLT

RE:RE:i like the opening

I would read it to also mean future trials (GBM & lung) will be designed...

October 23, 2023

V.TLT

RE:RE:RE:RE:RE:Here we go again

NOtaPOOp--- no need to apologize to Foxx.  It's hard to tell if...

October 23, 2023

V.TLT

RE:RE:Here we go again

Oh good Budd showed up. Time for him to tell us all how misguided we are...

October 23, 2023

V.TLT

Upside to CR

Imagine what the CR % will look like when we start retreating patients who...

October 23, 2023

V.TLT

RE:RE:Does today's News release

Actually, the part about surveillance beyond 450 days is positive for TLT...

October 23, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study

Agreed all. Lets remeber too that a potential partner has to sell a deal to...

October 16, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Files US Patent for Enhanced Immunotherapy

Thanks DJ. 

October 5, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Files US Patent for Enhanced Immunotherapy

does anyone remeber if there is a 2023 Corporate Presentation? Its not on...

October 5, 2023

V.TLT

RE:RE:RE:RE:New Press Release - Theralase(R) Files US Patent for Enhanced Immunotherapy

Players in the CD47 space; Gilead and Pfizer each acquired smaller companies...

October 5, 2023

V.TLT

RE:RE:Buyout before PH3 data

Glad to see you're back foxx. Why don't you take up the torch and...

October 3, 2023

V.TLT

RE:Buyout before PH3 data

Point has 105m outstanding shares; 60% owned by institutions/15% by insiders...

October 3, 2023

V.TLT

RE:Buyout before PH3 data

Interesting find Enrique. Thanks. Definitely see the potential comparison...

October 3, 2023

V.TLT

RE:RE:GBM

Yes it is huge. Big pharma want to purchase preclinical assets teed up and...

September 28, 2023

V.TLT

RE:Keytruda story

Thanks Eog. Very interesting. BTW has anyone heard from Science First lately?

September 15, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

$5 million has been the goal all along. $5m working capital is the threshold...

September 12, 2023

V.TLT

RE:and so we wait

DJDawg, I think the answer to your intersting question lies somewhere...

September 8, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:PP Closed

That's all you got Bud? Now that's laughable. 

September 7, 2023

Prev 1 2 3 4 5 6 Next

Featured Company